case_images: PMC6503590_01
case_images: Gd-EDTA enhanced T1-weighted sagittal cranial MRI demonstrates multiple
  supratentorial contrast-enhanced lesions.
case_images: 10.1177_1756286419846818-fig1.jpg
case_images: PMC6503590_01_10.1177_1756286419846818-fig1.jpg
case_images: fig1-1756286419846818
case_images: MRI showed multiple gadolinium (Gd)-enhanced T1 lesions supratentorially and infratentorially (Figures 1 and 2) and two enhancing spinal cord lesions at the C5 and D4 level.
case_images: Axial FLAIR (a) and Gd-EDTA enhanced T1-weighted sequences (b) on cranial MRI
  demonstrate a large lesion in the left cerebellar peduncle.
case_images: 10.1177_1756286419846818-fig2.jpg
case_images: PMC6503590_01_10.1177_1756286419846818-fig2.jpg
case_images: fig2-1756286419846818
case_images: MRI showed multiple gadolinium (Gd)-enhanced T1 lesions supratentorially and infratentorially (Figures 1 and 2) and two enhancing spinal cord lesions at the C5 and D4 level.
case_images: Sagittal Gd-EDTA enhanced T1-weighted sequences on spinal MRI demonstrate
  multiple contrast-enhanced lesions at the C2, C7 and D1 level.
case_images: 10.1177_1756286419846818-fig3.jpg
case_images: PMC6503590_01_10.1177_1756286419846818-fig3.jpg
case_images: fig3-1756286419846818
case_images: MRI revealed multiple new Gd-enhanced T1 lesions in the cervical and thoracic cord (Figure 3).
case_images: Clinical evolution after cessation of fingolimod (FTY) in case 1. iv,
  intravenous; MP, methylprednisolone; OCR, ocrelizumab; PLEX, plasma
  exchange.
case_images: 10.1177_1756286419846818-fig4.jpg
case_images: PMC6503590_01_10.1177_1756286419846818-fig4.jpg
case_images: fig4-1756286419846818
case_images: The clinical events and measures after FTY cessation are summarized in Figure 4.
case_images: PMC6503590_02
case_images: Sagittal T2-weighted sequences on cranial MRI demonstrate a large brainstem
  lesion extending into the medulla.
case_images: 10.1177_1756286419846818-fig5.jpg
case_images: PMC6503590_02_10.1177_1756286419846818-fig5.jpg
case_images: fig5-1756286419846818
case_images: MRI revealed a large Gd-enhanced lesion extending from the pons to the medulla (Figure 5).
case_images: Clinical evolution after cessation of fingolimod (FTY) in case 2. iv,
  intravenous; MP, methylprednisolone; OCR, ocrelizumab.
case_images: 10.1177_1756286419846818-fig6.jpg
case_images: PMC6503590_02_10.1177_1756286419846818-fig6.jpg
case_images: fig6-1756286419846818
case_images: The clinical events and measures after FTY cessation are summarized in Figure 6.